The contribution of hemolysis to early jaundice in normal newborns
- PMID: 16818575
- DOI: 10.1542/peds.2005-3042
The contribution of hemolysis to early jaundice in normal newborns
Abstract
Objective: Neonatal jaundice is the result of an imbalance between bilirubin production and elimination, and our objective was to clarify the contribution of an increase in bilirubin production to hyperbilirubinemia in newborns.
Methods: We measured the end-tidal carbon monoxide concentration corrected for ambient carbon monoxide concentration in 108 jaundiced newborns (total serum bilirubin level >75th percentile) and 164 control newborns in our well-infant nursery, for the first 4 days after birth.
Results: Mean end-tidal carbon monoxide levels decreased in the control infants in the first 4 days but increased in the hyperbilirubinemic group. The differences between the jaundiced and nonjaundiced infants were statistically significant on all days.
Conclusions: Before hospital discharge, most infants with bilirubin levels >75th percentile are producing significantly more bilirubin than those with lower bilirubin levels. Because the ability of newborns to conjugate bilirubin is significantly impaired in the first few days, even a small increase in the rate of production can contribute to the development of hyperbilirubinemia. These data suggest that increased heme catabolism is an important mechanism responsible for hyperbilirubinemia in the first 4 days after birth.
Similar articles
-
Prediction of hyperbilirubinemia in near-term and term infants.J Perinatol. 2001 Dec;21 Suppl 1:S63-72; discussion S83-7. doi: 10.1038/sj.jp.7210638. J Perinatol. 2001. PMID: 11803421
-
Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs' test with ETCOc for detecting significant jaundice.J Perinatol. 2002 Jul-Aug;22(5):341-7. doi: 10.1038/sj.jp.7210702. J Perinatol. 2002. PMID: 12082466
-
Erythroid apoptosis in idiopathic neonatal jaundice.Pediatrics. 2008 May;121(5):e1348-51. doi: 10.1542/peds.2007-2215. Epub 2008 Apr 21. Pediatrics. 2008. PMID: 18426853
-
The jaundiced newborn. Understanding and managing transitional hyperbilirubinemia.Minerva Pediatr. 2002 Oct;54(5):373-82. Minerva Pediatr. 2002. PMID: 12244276 Review.
-
Understanding neonatal jaundice: a perspective on causation.Pediatr Neonatol. 2010 Jun;51(3):143-8. doi: 10.1016/S1875-9572(10)60027-7. Pediatr Neonatol. 2010. PMID: 20675237 Review.
Cited by
-
A Novel Drug with Potential to Treat Hyperbilirubinemia and Prevent Liver Damage Induced by Hyperbilirubinemia: Carbon Dots Derived from Platycodon grandiflorum.Molecules. 2023 Mar 17;28(6):2720. doi: 10.3390/molecules28062720. Molecules. 2023. PMID: 36985691 Free PMC article.
-
Reference intervals for reticulocyte parameters of infants during their first 90 days after birth.J Perinatol. 2016 Jan;36(1):61-6. doi: 10.1038/jp.2015.140. Epub 2015 Oct 29. J Perinatol. 2016. PMID: 26513452
-
A zebrafish model for studying the mechanisms of newborn hyperbilirubinemia and bilirubin-induced neurological damage.Front Cell Dev Biol. 2023 Nov 14;11:1275414. doi: 10.3389/fcell.2023.1275414. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38033855 Free PMC article.
-
The prevalence of neonatal jaundice and risk factors in healthy term neonates at National District Hospital in Bloemfontein.Afr J Prim Health Care Fam Med. 2018 Apr 12;10(1):e1-e6. doi: 10.4102/phcfm.v10i1.1582. Afr J Prim Health Care Fam Med. 2018. PMID: 29781686 Free PMC article.
-
HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis.J Mol Med (Berl). 2015 Aug;93(8):857-66. doi: 10.1007/s00109-015-1294-y. Epub 2015 May 28. J Mol Med (Berl). 2015. PMID: 26017143
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources